Journal Information
Vol. 16. Issue 6.
Pages 499-501 (November - December 2020)
Vol. 16. Issue 6.
Pages 499-501 (November - December 2020)
Case Report
Full text access
Trichorhinophalangeal syndrome
Síndrome tricorinofalángico
Carmen Vargas Lebróna, Maria Dolores Ruiz Montesinoa,
Corresponding author

Corresponding author.
, Virginia Moreira Navarretea, Juan Ignacio Aróstegui Gorospeb
a Servicio de Reumatología, Hospital Universitario Virgen Macarena, Sevilla, Spain
b Servicio de Inmunología. Hospital Clínic, Barcelona, Spain
This item has received
Article information
Full Text
Download PDF
Figures (3)
Show moreShow less

Trichorhinophalangeal syndrome I (TPRSI) has an autosomal dominant inheritance; the proportion of "de novo" cases is unknown.1 It is characterised by unique facial features, bulbous nose, flat and elongated nasolabial furrow, thin hair and slow growth. Skeletal abnormalities that include short phalanges and metacarpals -brachydactyly-, cone-shaped epiphyses, hip dysplasia and short stature.1–3

Trichorhinophalangeal síndrome
Radiological images
Skeletal abnormalities

El síndrome tricorinofalángico I (TPRSI) tiene una herencia autosómica dominante, la proporción de casos “de novo” es desconocida.1 Se caracteriza por rasgos faciales únicos, nariz de extremo bulboso, surco nasolabial plano y alargado, cabello escaso y de crecimiento lento. Anomalías esqueléticas que incluyen falanges y metacarpianos cortos -braquidactilia-, epífisis en forma de cono, displasia de cadera y estatura baja.1–3 Presentamos una familia con 7 miembros afectos de TRPSI.

Palabras clave:
Síndrome tricorinofalángico
Imágenes radiológicas
Anomalías esqueléticas
Full Text

Trichorhinophalangeal syndromes (TRPS) are rare congenital syndromes that are caused by a chromosome alteration. These include TPRS I—or Giedion—(caused by a heterocygotic pathogenic variant in TRPSI) and TPRS III—or Langer-Giedion — a phenotypic variant of the previous type—, and TPRS II —or Sugio-Kajii— (caused by a deletion in genes adjacent to TPRSI, RAD21 and EXTI). They are characterised by skeletal anomalies, delayed growth, distinctive facial features, ectodermic alterations—thin hair that is depigmented and hardly grows, dystrophic nails and small breasts—and in TRPS II multiple osteochondromas, as well as varying degrees of intellectual disability. TRPS I or Giedion (MIM 190350) is a malformative syndrome characterised by facial and skeletal alterations. It is inherited with a pattern of autosomal dominance with high penetrance and variable expressivity, associated with alterations in chromosome 8q24.1.It is characterised by unique facial characteristics, a nose with a bulbous tip, a flat and prolonged nasolabial groove, little hair and slow growth. The skeletal anomalies include short phalanges and metacarpals – brachydactily –, cone-shaped epiphyses, hip dysplasia and short height.1–3

Clinical case

We present the cases of a family with 7 affected members in 4 generations. The cases were diagnosed based on a female patient with the facial and skeletal characteristics of the syndrome (Figs. 1 and 2). Only 3 members of the family with similar physical characteristics are being monitored by rheumatology, and their history does not mention urethral, endocrine or renal alteration or disease; they all have sparse hair as dermatological involvement. The youngest member has slight scoliosis and pectus excavatum as a differentiating trait from the others. Our patient was previously diagnosed with rheumatoid arthritis and psoriatic arthritis. She consulted due to deformity and discomfort in the interphalangeal joints of both hands. The heterozygous variant c.2894 G > A (p.Arg965His) was detected in the TPRSI gene. This is known to be a pathogenic variant in the said syndrome. There is a 50% risk of transmission to descendents4 (Fig. 3).

Figure 1.

Sparse hair and bulbous nose.

Figure 2.

Cone-shaped epiphysis.

Figure 3.

Family tree: circles are women, squares are men, figures shaded in blue are affected.


The name TRPS covers 3 rare genetic diseases that are characterised by craniofacial and skeletal anomalies. The TPRSI (OMIM 604386) gene in chromosome 8q23.1-q24.1 is associated with the development and differentiation of bones, kidneys and hair follicles.1,2,5 Diagnosis of this rare syndrome is based on the physical and radiological characteristics of the patients, and it is confirmed by the detection of a pathogenic genetic variant. Detection in an adult, as in this case, makes it possible to avoid errors in treatment, which in TRPS is exclusively supportive, with analgesia and orthopaedic measures when necessary.1–3


TRPS are rare genetic diseases, and awareness of them makes it possible to avoid diagnostic errors and subsequent possibly harmful treatments.

Conflict of interests

The authors have no conflict of interests to declare.

Trichorhinophalangeal Syndrome GeneReviews® [Internet],
M. Vaccaro, G. Tchernev, U. Wollina, T. Lotti, C. Guarneri.
Trichorhinophalangeal Syndrome.
Open Access Maced J Med Sci, 5 (2017), pp. 486-489
P. Terrádez Marco, I. Güemes Heras, A. Cuñat Romero, A. Plasencia Couchud, R. Fornés Vivas, A. Pérez.
Fourth case of Langer-Giedion syndrome without TRPS1 deletion. Genetic and phenotypic variability.
Rev Esp Endocrinol Pediatr, 6 (2015), pp. 61-65
F. Hazan, H.A. Korkmaz, K. Yararbaş, W. Wuyts, A. Tükün, Collaborator.
Trichorhinophalangeal syndrome type II presenting with short stature in a child.
Arch Argent Pediatr., 114 (2016), pp. 403-407
F.J. Kaiser, P. Brega, M.L. Raff, P.H. Byers, S. Gallati, T.T. Kay, et al.
Novel missense mutations in the TRPS1 transcription factor define the nuclear localization signal.
Eur J Hum Genet., 12 (2004), pp. 121-126

Please cite this article as: Vargas Lebrón C, Ruiz Montesino MD, Moreira Navarrete V, Aróstegui Gorospe JI. Síndrome tricorinofalángico. Reumatol Clin. 2020;16:499–501.

Copyright © 2018. Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología
Reumatología Clínica (English Edition)
Article options
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?